Cargando…
MON-591 Effect of Liraglutide Treatment on Proglucagon-Derived Peptides
Liraglutide is a glucagon-like peptide 1 receptor agonist (GLP-1ra) and has 97% homology to native GLP-1. Native GLP-1 derives from proglucagon, which is also a prohormone for other peptides including GLP-2, glucagon, oxytomodulin, glicentin, and major proglucagon fragment. Aside from GLP-1 and gluc...
Autores principales: | Kim, Sun, Abbasi, Fahim, Nachmanoff, Clara, Kumar, Ajay, Kalra, Bhanu, Savjani, Gopal, Mantzoros, Christos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208465/ http://dx.doi.org/10.1210/jendso/bvaa046.1288 |
Ejemplares similares
-
MON-605 Serum CD163, but Not Gal-3, Predicts Response to Liraglutide Therapy in Obese Patients
por: Mat, Arimin, et al.
Publicado: (2020) -
SUN-591 PAPP-A Inhibition - a Novel Anti-Obesity Therapeutic Approach
por: Ramakrishna, Akhila, et al.
Publicado: (2020) -
ODP591 Obesity and Weight Loss Apps in COVID-19 Era: Do They Help Both the Doctor and the Patient?
por: Lawrence, Rebecca, et al.
Publicado: (2022) -
SAT-591 Lack of Adipose-Specific Hexose-6-Phosphate Dehydrogenase Improves Fat Metabolic Phenotype and Increases Insulin Sensitivity in Mice
por: Wang, Jian, et al.
Publicado: (2020) -
MON-120 Effect of Weight Loss on Physical Function Measured by the 6-Minute Walking Distance Test in Individuals with Obesity: Results from the SCALE IBT Trial of Liraglutide 3.0 Mg
por: Rubino, Domenica, et al.
Publicado: (2019)